Wealth Enhancement Advisory Services
MIRM icon

Wealth Enhancement Advisory Services’s Mirum Pharmaceuticals MIRM Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$169K Buy
7,042
+942
+15% +$94.6K ﹤0.01% 3652
2026
Q1 		$67.7K Buy
6,100
+2,340
+62% +$220K ﹤0.01% 3391
2025
Q4 		$292K Sell
3,760
-3,139
-45% -$225K ﹤0.01% 2944
2025
Q3 		$509K Sell
6,899
-4,946
-42% -$314K ﹤0.01% 2353
2025
Q2 		$596K Sell
11,845
-4,840
-29% -$215K ﹤0.01% 2097
2025
Q1 		$752K Buy
16,685
+339
+2% +$16K ﹤0.01% 1774
2024
Q4 		$676K Buy
16,346
+11
+0.1% +$458 ﹤0.01% 1783
2024
Q3 		$637K Sell
16,335
-74
-0.5% -$2.95K ﹤0.01% 1656
2024
Q2 		$561K Sell
16,409
-15,080
-48% -$395K ﹤0.01% 1583
2024
Q1 		$791K Sell
31,489
-862
-3% -$23.7K ﹤0.01% 1342
2023
Q4 		$955K Buy
32,351
+3
+0% +$91 ﹤0.01% 1196
2023
Q3 		$1.02M Buy
+32,348
New +$886K ﹤0.01% 1085

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wealth Enhancement Advisory Services's MIRM Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Mirum Pharmaceuticals (MIRM) stake by 15% in Q2 2026, buying an estimated $94.6K and bringing the position to 7,042 shares worth $169K. The position accounts for ﹤0.01% of the portfolio, ranked #3652.

Wealth Enhancement Advisory Services first reported a position in MIRM in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.02M in Q3 2023. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Wealth Enhancement Advisory Services held 7,042 shares of Mirum Pharmaceuticals worth $169K as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 942 Mirum Pharmaceuticals shares in Q2 2026, an estimated $94.6K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3652 holding.
  • Wealth Enhancement Advisory Services first reported a position in Mirum Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
  • Wealth Enhancement Advisory Services's Mirum Pharmaceuticals position peaked at $1.02M in Q3 2023.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.